Mechanism-Based Disease Progression Model Describing Host-Pathogen Interactions During the Pathogenesis of Acinetobacter baumannii Pneumonia.

CPT: Pharmacometrics & Systems Pharmacology
John K DiepGauri G Rao

Abstract

The emergence of highly resistant bacteria is a serious threat to global public health. The host immune response is vital for clearing bacteria from the infected host; however, the current drug development paradigm does not take host-pathogen interactions into consideration. Here, we used a systems-based approach to develop a quantitative, mechanism-based disease progression model to describe bacterial dynamics, host immune response, and lung injury in an immunocompetent rat pneumonia model. Previously, Long-Evans rats were infected with Acinetobacter baumannii (A. baumannii) strain 307-0294 at five different inocula and total lung bacteria, interleukin-1beta (IL-1β), tumor necrosis factor-α (TNF-α), cytokine-induced neutrophil chemoattractant 1 (CINC-1), neutrophil counts, and albumin were quantified. Model development was conducted in ADAPT5 version 5.0.54 using a pooled approach with maximum likelihood estimation; all data were co-modeled. The final model characterized host-pathogen interactions during the natural time course of bacterial pneumonia. Parameters were estimated with good precision. Our expandable model will integrate drug effects to aid in the design of optimized antibiotic regimens.

References

Jul 1, 1996·Biological Signals·T J StandifordS L Kunkel
Mar 28, 1998·British Journal of Clinical Pharmacology·A Sharma, W J Jusko
Mar 13, 2001·Annual Review of Immunology·K W MooreA O'Garra
Apr 30, 2002·Seminars in Immunology·Joseph P Mizgerd
Sep 17, 2004·Experimental Lung Research·Paul R KnightBruce A Holm
Oct 27, 2004·Immunology·Lynn M WilliamsBrian M J Foxwell
Dec 31, 2004·Proceedings of the National Academy of Sciences of the United States of America·Denise LauStephan Baldus
Oct 17, 2006·Molecular Microbiology·Sigrid C J De KeersmaeckerKathleen Marchal
Jan 24, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lee J QuintonJoseph P Mizgerd
Feb 20, 2007·Immunity·Philippe J Sansonetti, James P Di Santo
Jun 15, 2007·PLoS Computational Biology·Juilee ThakarRéka Albert
Jul 25, 2007·Infection and Immunity·David K R KaraolisTheodore J Standiford
Jun 11, 2008·Infection and Immunity·Thomas A RussoAnthony A Campagnari
Dec 6, 2008·Journal of Theoretical Biology·Andreas HandelBruce R Levin
Oct 6, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Amy E MorrisShawn J Skerrett
Mar 23, 2010·Cell·Osamu Takeuchi, Shizuo Akira
Feb 9, 2011·Journal of Theoretical Biology·Amber M SmithFrederick R Adler
Feb 16, 2011·Omics : a Journal of Integrative Biology·Mones S Abu-AsabHakima Amri
May 3, 2011·American Journal of Respiratory Cell and Molecular Biology·Gustavo Matute-BelloUNKNOWN Acute Lung Injury in Animals Study Group
Mar 7, 2012·Microbiology and Molecular Biology Reviews : MMBR·Jennifer R TisoncikMichael G Katze
Jan 30, 2013·Antimicrobial Agents and Chemotherapy·Rachel L SoonAlan Forrest
Feb 26, 2013·Nature Reviews. Immunology·Elzbieta Kolaczkowska, Paul Kubes
Apr 5, 2013·Seminars in Immunopathology·Sébastien JaillonAlberto Mantovani
Apr 20, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W BoucherUNKNOWN Infectious Diseases Society of America
May 18, 2013·Journal of Pharmaceutical Sciences·William J Jusko
Sep 21, 2013·Annual Review of Pathology·Tanya N MayadasClifford A Lowell
Mar 7, 2014·Journal of Theoretical Biology·Ericka MochanGilles Clermont
May 21, 2014·Proceedings of the National Academy of Sciences of the United States of America·Peter Ankomah, Bruce R Levin
Mar 6, 2015·Journal of Cheminformatics·Karen A Ryall, Aik Choon Tan
Oct 31, 2015·Pharmacology Research & Perspectives·Hoi-Kei LonWilliam J Jusko

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Intensive Care Medicine
Jordi Rello, Emili Diaz
Medicina clínica
F J Fernández-FernándezP Sesma
Médecine et maladies infectieuses
K BachoumasJ Reignier
Journal of Neurosurgery
Nikolaos Sakellaridis, Vasilios Kontoyannis
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
G G RaoA Forrest
© 2022 Meta ULC. All rights reserved